Clinical trial · Interventional
Sexual Therapy and Rehabilitation After Treatment for Ovarian Cancer (START-OC): A Pilot Intervention
NCT02287519CI-TRIAL-00043697START-OCcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This research study is evaluating an educational intervention for women who have experienced changes in sexual function after treatment for ovarian cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ovarian Cancer | Malignant Ovarian Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Group Session | Behavioral | — | UNRESOLVED |
| Telephone Coaching Session | Behavioral | — | UNRESOLVED |
| Webinar | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Support Group
- description
- * One group educational session will include information on resources, self-help strategies, and relaxation techniques. * One telephone coaching session after the group session Or * Pilot webinar format of the educational session
- interventionNames
- Behavioral: Group Session
- Behavioral: Telephone Coaching Session
- Behavioral: Webinar
Primary outcomes (1)
- measure
- Change in sexual dysfunction will be assessed by change on the Female Sexual Function Index (FSFI).
- timeFrame
- Baseline, 2 month Post Intervention, 6 Month Post Intervention
Secondary outcomes (4)
- measure
- Change in sexual self-efficacy will be assessed by change on the Sexual Self-Efficacy Scale
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Women diagnosed with Stage1-IV ovarian cancer * Prognosis of at least one year to live (as assessed by provider) * Endorsement of at least one sexual symptom (see Appendix A for eligibility screening) * English speaking * Signed informed consent Exclusion Criteria: * History of pelvic radiation * Cognitive impairment which would interfere with the ability to participate in the study (as assessed by provider)
References
Publications (0)
Data not yet available
No reference posted for this study.